We are live on !
Find out more
Oracle Alpha Portfolio holdings
AUM
$55.7M
Turnover
44.04%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$55.7M
AUM Growth
-$21.5M
(-28%)
Cap. Flow
-$24.9M
Cap. Flow % of AUM
Cap. Flow %
-44.61%
Top 10 Holdings %
Top 10 Hldgs %
13.49%
Holding
277
New
30
Increased
43
Reduced
112
Closed
92
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Macy's
M
|
+$518K |
| 2 |
Victoria's Secret
VSXY
|
+$368K |
| 3 |
Best Buy
BBY
|
+$354K |
| 4 |
Micron Technology
MU
|
+$340K |
| 5 |
Nextpower Inc. Common Stock
NXT
|
+$331K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$778K |
| 2 |
Merck
MRK
|
+$706K |
| 3 |
Cytokinetics
CYTK
|
+$518K |
| 4 |
G-III Apparel Group
GIII
|
+$509K |
| 5 |
Texas Instruments
TXN
|
+$462K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.05% |
| 2 | Healthcare | 15.86% |
| 3 | Consumer Discretionary | 15.01% |
| 4 | Financials | 12.18% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Dole
DOLE
$1.23B
| $170K | 0.31% |
14,262
-15,814
| -53% | -$183K |
2023 Q4
1 quarter
|
|
152
Nurix Therapeutics
NRIX
$2.93B
| $170K | 0.3% |
11,538
-5,896
| -34% | -$63.4K |
2023 Q4
1 quarter
|
|
153
Asana
ASAN
$2.57B
| $169K | 0.3% |
10,887
-125
| -1% | -$2.24K |
2023 Q4
1 quarter
|
|
154
Cushman & Wakefield Ltd
CWK
$3.12B
| $168K | 0.3% |
16,082
-1,568
| -9% | -$15.9K |
2023 Q4
1 quarter
|
|
155
ARKO Corp
ARKO
$425M
| $156K | 0.28% |
27,427
-9,576
| -26% | -$69.9K |
2023 Q4
1 quarter
|
|
156
Lands' End
LE
$281M
| $149K | 0.27% |
+13,713
| New | +$125K |
2024 Q1
0 quarters
|
|
157
Medallion Financial
MFIN
$228M
| $148K | 0.27% |
18,677
-1,522
| -8% | -$13.7K |
2023 Q4
1 quarter
|
|
158
Sprinklr
CXM
$1.58B
| $147K | 0.26% |
11,968
-689
| -5% | -$8.77K |
2023 Q4
1 quarter
|
|
159
Coursera
COUR
$917M
| $146K | 0.26% |
10,379
-7,511
| -42% | -$128K |
2023 Q4
1 quarter
|
|
160
DELISTED
89bio
ETNB
| $144K | 0.26% |
12,414
-3,106
| -20% | -$34.4K |
2023 Q4
1 quarter
|
|
161
DELISTED
Big Lots, Inc.
BIG
| $144K | 0.26% |
+33,306
| New | +$176K |
2024 Q1
0 quarters
|
|
162
Hawaiian Electric Industries
HE
$1.51B
| $140K | 0.25% |
12,432
-2,896
| -19% | -$36.8K |
2023 Q4
1 quarter
|
|
163
Pediatrix Medical
MD
$2.33B
| $138K | 0.25% |
13,753
-3,554
| -21% | -$33.1K |
2023 Q4
1 quarter
|
|
164
Newmark Group
NMRK
$2.09B
| $137K | 0.25% |
12,324
-3,218
| -21% | -$33.7K |
2023 Q4
1 quarter
|
|
165
GCM Grosvenor
GCMG
$773M
| $132K | 0.24% |
13,675
-737
| -5% | -$6.41K |
2023 Q4
1 quarter
|
|
166
Herbalife
HLF
$1.37B
| $123K | 0.22% |
+12,212
| New | +$131K |
2024 Q1
0 quarters
|
|
167
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $116K | 0.21% |
13,540
-2,845
| -17% | -$27.7K |
2023 Q4
1 quarter
|
|
168
DELISTED
Accolade Inc
ACCD
| $113K | 0.2% |
+10,770
| New | +$122K |
2024 Q1
0 quarters
|
|
169
Amcor
AMCR
$21.9B
| $110K | 0.2% |
2,314
+246
| +12% | +$11.5K |
2023 Q4
1 quarter
|
|
170
Peloton Interactive
PTON
$2.25B
| $110K | 0.2% |
25,599
+11,117
| +77% | +$54.9K |
2023 Q4
1 quarter
|
|
171
DELISTED
Agiliti Inc
AGTI
| $108K | 0.19% |
10,717
-3,285
| -23% | -$27.5K |
2023 Q4
1 quarter
|
|
172
DELISTED
Bridge Investment Group
BRDG
| $105K | 0.19% |
15,387
+1,431
| +10% | +$11.9K |
2023 Q4
1 quarter
|
|
173
Ironwood Pharmaceuticals
IRWD
$578M
| $103K | 0.18% |
11,804
-3,371
| -22% | -$40.9K |
2023 Q4
1 quarter
|
|
174
GPGI Inc
GPGI
$3.24B
| $101K | 0.18% |
16,862
-23,040
| -58% | -$104K |
2023 Q4
1 quarter
|
|
175
AGNC Investment
AGNC
$11B
| $99.2K | 0.18% |
10,017
-7,808
| -44% | -$75.3K |
2023 Q4
1 quarter
|
|
Similar funds
RCA
Oracle Alpha's Q1 2024 Portfolio in Review
As of Q1 2024, Oracle Alpha held 277 positions worth $55.7M, down 28% from $77.3M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Oracle Alpha withdrew a net $24.9M in Q1 2024, closing 92 positions and reducing 112 holdings. Its most notable exit was Merck, an estimated $706K position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Oracle Alpha opened a new position in Victoria's Secret worth $291K.
- Oracle Alpha's largest Q1 2024 buy was Victoria's Secret: 14,995 shares worth $291K.
- Oracle Alpha added most to Macy's in Q1 2024, an estimated $518K increase.
- Oracle Alpha's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $778K.
- Oracle Alpha fully exited Merck in Q1 2024, selling an estimated $706K.
- Oracle Alpha's ten largest holdings make up 13% of its $55.7M portfolio in Q1 2024.
- Oracle Alpha opened 30 new positions and closed 92 in Q1 2024.
- Oracle Alpha's portfolio value fell 28% quarter-over-quarter to $55.7M.
Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.